肾活检在免疫检查点抑制剂相关性 AKI 中的作用。
The Role of Kidney Biopsy in Immune Checkpoint Inhibitor-Associated AKI.
机构信息
Division of Nephrology and Hypertension, University Hospitals Cleveland Medical Center, Cleveland, Ohio.
Division of Nephrology, Hypertension and Renal Transplant, University of Florida, Gainesville, Florida.
出版信息
Kidney360. 2022 Jan 13;3(3):530-533. doi: 10.34067/KID.0000232022. eCollection 2022 Mar 31.
Abstract
AKI in the setting of immune checkpoint inhibitors.Need for kidney biopsy for diagnosis of immune checkpoint inhibitors.Importance of pathology in diagnosis of immune checkpoint inhibitor-induced AKI.
摘要
免疫检查点抑制剂相关急性肾损伤。为明确诊断需行肾活检。免疫检查点抑制剂相关性急性肾损伤的病理诊断意义。
相似文献
1
The Role of Kidney Biopsy in Immune Checkpoint Inhibitor-Associated AKI.肾活检在免疫检查点抑制剂相关性 AKI 中的作用。
Kidney360. 2022 Jan 13;3(3):530-533. doi: 10.34067/KID.0000232022. eCollection 2022 Mar 31.
2
Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study.免疫检查点抑制剂在临床实践中的肾脏不良反应：ImmuNoTox 研究。
Eur J Cancer. 2021 Apr;147:29-39. doi: 10.1016/j.ejca.2021.01.005. Epub 2021 Feb 16.
3
Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.免疫检查点抑制剂相关急性肾损伤和死亡率：一项观察性研究。
PLoS One. 2021 Jun 8;16(6):e0252978. doi: 10.1371/journal.pone.0252978. eCollection 2021.
4
Kidney Injury in Patients Treated with Immune Checkpoint Inhibitors Does Not Meet KDIGO-AKI Criteria.免疫检查点抑制剂治疗患者的肾损伤不符合 KDIGO-AKI 标准。
Kidney360. 2021 Dec 21;3(3):524-529. doi: 10.34067/KID.0006752021. eCollection 2022 Mar 31.
5
Combination therapy with immune check point inhibitors and acute kidney injury.免疫检查点抑制剂与急性肾损伤的联合治疗
Acta Oncol. 2023 Feb;62(2):121-125. doi: 10.1080/0284186X.2023.2176255. Epub 2023 Feb 8.
6
Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: PRO.对于发生免疫检查点抑制剂相关急性肾损伤的患者，再次激发是否合适？：正方观点。
Kidney360. 2021 Sep 17;3(5):799-802. doi: 10.34067/KID.0003962021. eCollection 2022 May 26.
7
Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: COMMENTARY.对于发生免疫检查点抑制剂相关急性肾损伤的患者，再次激发是否合适？：评论
Kidney360. 2021 Sep 17;3(5):806-808. doi: 10.34067/KID.0005592021. eCollection 2022 May 26.
8
Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020.免疫检查点抑制剂相关肾毒性：2020 更新版。
Kidney360. 2020 Jan 14;1(2):130-140. doi: 10.34067/KID.0000852019. eCollection 2020 Feb 27.
9
Acute kidney injury in patients treated with immune checkpoint inhibitors: a single-center retrospective study.接受免疫检查点抑制剂治疗患者的急性肾损伤：一项单中心回顾性研究。
Ren Fail. 2024 Dec;46(1):2326186. doi: 10.1080/0886022X.2024.2326186. Epub 2024 Mar 11.
10
Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: Commentary.应进行肾活检以明确免疫检查点抑制剂相关急性肾损伤的病因：评论
Kidney360. 2020 Feb 11;1(3):166-168. doi: 10.34067/KID.0001072019. eCollection 2020 Mar 26.
引用本文的文献
1
Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.与免疫检查点抑制剂肾炎相关的临床特征：一项单中心临床病例系列研究。
Cancer Immunol Immunother. 2024 Aug 6;73(10):200. doi: 10.1007/s00262-024-03775-6.
2
Crescentic Fibrillary Glomerulonephritis in the Setting of Immune Checkpoint Inhibitor Therapy: A Report of Two Cases.免疫检查点抑制剂治疗背景下的新月体性纤维性肾小球肾炎：两例报告
Glomerular Dis. 2022 Dec 30;3(1):69-74. doi: 10.1159/000528881. eCollection 2023 Jan-Dec.
3
Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?免疫疗法与肾病谱：我们是否应该个体化治疗？
Front Med (Lausanne). 2022 Jun 14;9:906565. doi: 10.3389/fmed.2022.906565. eCollection 2022.
4
Kidney Biopsy in Patients with Cancer along the Last Decade: A Multicenter Study.过去十年癌症患者的肾活检：一项多中心研究。
J Clin Med. 2022 May 21;11(10):2915. doi: 10.3390/jcm11102915.
Zotero 插件